Incidence and efficacy of strategies for preventing hepatic encephalopathy following transjugular intrahepatic portosystemic shunt: A meta-analysis

doi:10.4254/wjh.v17.i4.104890

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (818)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-8) series, Tables (1-3) series.

Item

Count

PDF

HTML

529

Figures (1-8)

Tables (1-3)

Sum=693

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=80

Apr 27, 2025 (publication date) through May 17, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Hepatol. Apr 27, 2025; 17(4): 104890
Published online Apr 27, 2025. doi: 10.4254/wjh.v17.i4.104890

Full Size Figure Download Figure

Figure 8 Network meta-analysis. A: Network diagram; B: Funnel plot; C: Sucra cumulative probability plot. LM: Lactulose monoprophylaxis; RM: Rifaximin monoprophylaxis; LR: Lactulose and rifaximin; NM: No prophylactic medication; LOLA: L-ornithin-l-aspartate; ALB: Albumin. D: League chart. NM: No prophylactic medication; ALB: Albumin; LOLA: L-ornithin-l-aspartate; LR: Lactulose and rifaximin; RM: Rifaximin monoprophylaxis; LM: Lactulose monoprophylaxis.

Citation: Xu XT, Jiang MJ, Fu YL, Xie F, Li JJ, Meng QH. Incidence and efficacy of strategies for preventing hepatic encephalopathy following transjugular intrahepatic portosystemic shunt: A meta-analysis. World J Hepatol 2025; 17(4): 104890
URL: https://www.wjgnet.com/1948-5182/full/v17/i4/104890.htm
DOI: https://dx.doi.org/10.4254/wjh.v17.i4.104890